Snowball logo
logo
6006

Vcanbio Cell & Gene Engineering Corp Ltd

600645 SHG
¥17.90-¥0.16  (0.89%)
Estimate
P/E
71.6
EPS
0.25
Beta
-0.162
Growth
Revenue, YoY
-6.44%
Net income, YoY
23.75%
FCF, YoY
46.76%
About the company
Ticker
600645
ISIN
CNE000000545
Country
China
Sector (GICS)
Healthcare
Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, engages in the preparation and storage of cell detection tests in the People's Republic of China. It offers cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, immune cells, adipose stem cells and dental stem cells. The company also provides prenatal genetic testing for pregnancy, children and adults, disease inheritance, and disease susceptibility; and in vitro diagnostic raw materials such as monoclonal antibodies and polyclonal antibody products, and the research, development, production and sales of Class I, Class II and Class III in vitro diagnostic reagents and medical devices. In addition, it is involved in the research, development, production, and sales of biological genes, proteins, antibodies, and pharmaceutical intermediates. The company was founded in 1992 and is based in Tianjin, the People's Republic of China.

Frequently asked questions

What sector does Vcanbio Cell & Gene Engineering Corp Ltd (600645) operate in?

Vcanbio Cell & Gene Engineering Corp Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Vcanbio Cell & Gene Engineering Corp Ltd (600645) current stock price?

As of the latest data, Vcanbio Cell & Gene Engineering Corp Ltd stock price is CN¥17.90, with a previous close of CN¥18.06. Vcanbio Cell & Gene Engineering Corp Ltd lost -CN¥0.16 in the last trading session, representing a -0.89% loss.

What is Vcanbio Cell & Gene Engineering Corp Ltd (600645) current market capitalization?

Vcanbio Cell & Gene Engineering Corp Ltd market cap is approximately 8.38 billion.

What is Vcanbio Cell & Gene Engineering Corp Ltd (600645) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.25.

What is Vcanbio Cell & Gene Engineering Corp Ltd (600645) Price-to-Earnings (P/E) ratio?

Vcanbio Cell & Gene Engineering Corp Ltd current P/E ratio is 71.6.

Does Vcanbio Cell & Gene Engineering Corp Ltd (600645) pay dividends?

No. Vcanbio Cell & Gene Engineering Corp Ltd does not pay a dividend.

What is Vcanbio Cell & Gene Engineering Corp Ltd (600645) beta (volatility) score?

Vcanbio Cell & Gene Engineering Corp Ltd has a beta of -0.162, indicating lower volatility than the overall market.